Download PDF
Synlett 2022; 33(19): 1902-1906
DOI: 10.1055/a-1916-5335
letter

Direct Methenylation of 4-Alkylpyridines Using Eschenmoser’s Salt

Grant N. Shivers
,
Soe L. Tun
,
Shay L. McLean
,
F. Christopher Pigge  ∗
Financial support for G.N.S. was received from the Center for ­Biocatalysis and Bioprocessing, University of Iowa (NIH Predoctoral Training Program in Biotechnology, T32-GM008365). Funds for the purchase of a Bruker Avance Neo 400 NMR spectrometer were provided by the NSF-MRI Program (NSF-CHE-2017828).
› Further Information
    Permissions and Reprints All articles of this category


Abstract

4-Alkylpyridines are converted into conjugated 1,1-disubstituted alkenyl pyridines (vinyl pyridines) upon treatment with excess ethyl chloroformate, triethylamine, and Eschenmoser’s salt. The reaction proceeds under mild conditions via alkylidene dihydropyridine intermediates.

Key words

pyridine - alkylidene dihydropyridine - anhydrobase - alkylation - Eschenmoser’s salt - dearomatization

Supporting Information

    Supporting information for this article is available online at https://doi.org/10.1055/a-1916-5335.
  • Supporting Information


Publication History

Received: 07 July 2022

Accepted after revision: 02 August 2022

Accepted Manuscript online:
02 August 2022

Article published online:
02 September 2022

© 2022. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References and Notes

    • 1a Kiuru P, Yli-Kauhaluoma J. In Heterocycles in Natural Product Synthesis . Majumdar KC, Chattopadhyay SK. Wiley-VCH; Weinheim: 2011: 267
      CrossrefGoogle Scholar
    • 1b Khan E. ChemistrySelect 2021; 6: 3041
      Crossref
    • 1c Kennemur JG. Macromolecules 2019; 52: 1354
      Crossref
  • 2 Baumann M, Baxendale IR. Beilstein J. Org. Chem. 2013; 9: 2265
    CrossrefPubMed
  • 3 Blakemore DC, Castro L, Churcher I, Rees DC, Thomas AW, Wilson DM, Wood A. Nat. Chem. 2018; 10: 383
    CrossrefPubMed
  • 4 Stupnikova TV, Zemskii BP, Sagitullin RS, Kost AN. Chem. Heterocycl. Compd. 1982; 18: 217
    CrossrefPubMed
    • 6a Wasfy N, Rasheed F, Robidas R, Hunter I, Shi J, Doan B, Legault CY, Fishlock D, Orellana A. Chem. Sci. 2021; 12: 1503
      CrossrefPubMed
    • 6b Shi J, Sayyad A, Fishlock D, Orellana A. Org. Lett. 2021; 24: 48
      CrossrefPubMed
    • 8a Reeves JT, Tan Z, Reeves DC, Song JJ, Han ZS, Xu Y, Tang W, Yang B.-S, Razavi H, Harcken C, Kuzmich D, Mahaney PE, Lee H, Busacca CA, Senanayake CH. Org. Process Res. Dev. 2014; 18: 904
      Crossref
    • 8b Cockerill GS, Angell RM, Bedernjak A, Chuckowree I, Fraser I, Gascon-Simorte J, Gilman MS. A, Good JA. D, Harland R, Johnson SM, Ludes-Meyers JH, Littler E, Lumley J, Lunn G, Mathews N, McLellan JS, Paradowski M, Peeples ME, Scott C, Tait D, Taylor G, Thom M, Thomas E, Barber CV, Ward SE, Watterson D, Williams G, Young P, Powell K. J. Med. Chem. 2021; 64: 3658
      CrossrefPubMed
    • 8c Alexander RP, Warrellow GJ, Eaton MA. W, Boyd EC, Head JC, Porter JR, Brown JA, Reuberson JT, Hutchinson B, Turner P, Boyce B, Barnes D, Mason B, Cannell A, Taylor RJ, Zomaya A, Millican A, Leonard J, Morphy R, Wales M, Perry M, Allen RA, Gozzard N, Hughes B, Higgs G. Bioorg. Med. Chem. Lett. 2002; 12: 1451
      CrossrefPubMed
  • 9 Wasfy N, Doan B, Rasheed F, Fishlock D, Orellana A. ACS Catal. 2021; 11: 3251 ; and references cited
    CrossrefPubMed
    • 10a Álvarez R, Aramburu L, Gajate C, Vicente-Blázquez A, Mollinedo F, Medarde M, Peláez R. Bioorg. Chem. 2020; 98: 103755
      CrossrefPubMed
    • 10b Henegar KE, Ashford SW, Baughman TA, Sih JC, Gu R.-L. J. Org. Chem. 1997; 62: 6588
      Crossref
  • 11 Itoh M, Hirano K, Satoh T, Miura M. Org. Lett. 2014; 16: 2050
    CrossrefPubMed
  • 12 For a previous report describing the preparation of pyridine oligomers from alkylpyridines and Eschenmoser’s salt, see: Möhrle H, Pycior M, Wendisch D. Arch. Pharm. 1994; 327: 445
    Crossref
  • 13 Representative Procedure Reactions were performed in a 20 mL scintillation vial. To a solution of 1a (50.0 mg, 0.28 mmol, 1 equiv) and Et3N (3 equiv) in THF (2.8 mL) were added ClCO2Et (3.5 equiv) and Eschenmoser’s salt (1.5 equiv). The vial was capped and placed in a J-KEM Lab benchtop shaker heating block set to 66 °C and agitated until the reaction was complete as indicated by TLC (ca. 16 h). After cooling to rt, the solvent was evaporated, and the residue purified by flash column chromatography using 25–100% EtOAc in hexanes as the eluent to afford 2a as an orange oil (47. 4 mg, 89%).
  • 14 Characterization Data for 2a 1H NMR (400 MHz, CDCl3): δ = 8.65 (d, J = 5.9 Hz, 2 H), 7.31 (d, J = 5.9 Hz, 2 H), 6.00 (s, 1 H), 5.42 (s, 1 H), 3.52 (q, J = 7.1 Hz, 2 H), 2.01 (s, 3 H), 1.14 (t, J = 7.1 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 170.3, 150.9, 145.2, 143.4, 120.0, 117.4, 41.6, 22.2, 13.1. HRMS (ESI+): m/z calcd for C11H15N2O [M + H]+: 191.1179; found: 191.1177.